acétyl-L-carnitine HCl

Reported Uses

• NOTE: see Herb & Supplement Effectiveness Rating Definitions table
• ADHD [Insufficient Evidence]
• age-related cognitive decline [Possibly Effective]
• alcohol withdrawal sx [Possibly Effective]
• Alzheimer dz [Possibly Effective]
• amenorrhea [Insufficient Evidence]
• amyotrophic lateral sclerosis [Insufficient Evidence]
• athletic performance [Insufficient Evidence]
• Bell palsy [Insufficient Evidence]
• bipolar disorder [Insufficient Evidence]
• carpel tunnel syndrome [Insufficient Evidence]
• cataracts [Insufficient Evidence]
• chronic fatigue syndrome [Insufficient Evidence]
• depression [Possibly Effective]
• diabetes mellitus [Insufficient Evidence]
• diabetic neuropathy [Possibly Effective]
• Down syndrome [Insufficient Evidence]
• dyslipidemia [Insufficient Evidence]
• fatigue, age-related [Possibly Effective]
• fatigue, cancer-related [Insufficient Evidence]
• fatigue, multiple sclerosis-related [Insufficient Evidence]
• female infertility [Insufficient Evidence]
• fibromyalgia [Insufficient Evidence]
• fragile X syndrome [Insufficient Evidence]
• frailty [Insufficient Evidence]
• hepatic encephalopathy [Insufficient Evidence]
• hepatotoxicity, toxin-induced [Insufficient Evidence]
• HTN [Insufficient Evidence]
• Lyme dz [Insufficient Evidence]
• male infertility [Possibly Effective]
• obesity [Insufficient Evidence]
• peripheral neuropathy [Insufficient Evidence]
• peripheral neuropathy, antiretroviral-assoc. [Insufficient Evidence]
• peripheral neuropathy, chemo-induced [Possibly Ineffective]
• Peyronie dz [Insufficient Evidence]
• polycystic ovary syndrome [Insufficient Evidence]
• schizophrenia [Insufficient Evidence]
• sciatica [Insufficient Evidence]
• skin aging [Insufficient Evidence]
• stroke [Insufficient Evidence]
• testosterone deficiency, age-related [Insufficient Evidence]